Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q4 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today.
Total revenue fell 7% year-over-year to $2.54 billion.
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/02/Biogen-Q4-2022-Earnings-Infographic-616x1024.jpg)
Net income attributable to Biogen Inc. was $550.4 million, or $3.79 per share, compared to $368.2 million, or $2.50 per share, last year. Adjusted EPS rose 19% to $4.05.
Both the top and bottom line numbers beat expectations.
For the full year of 2023, adjusted EPS is expected to range between $15.00-16.00.
Prior performance
![Biogen Q3 2022 earnings infographic](https://cdn.news.alphastreet.com/wp-content/uploads/2022/10/Biogen-Q3-2022-earnings-infographic-616x1024.jpg)
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%